74.78

6.58% 4.62

Pre-market: 75.90 1.12 +1.50%

Disc Medicine Inc (IRON)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Disc Medicine Inc stock is traded at $74.78, with a volume of 1.90M. It is up +6.58% in the last 24 hours and up +9.78% over the past month. Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Previous Close:

$70.16

Open:

$70.21

24h Volume:

1.90M

Relative Volume:

3.78

Market Cap:

$2.86B

Revenue:

Net Income/Loss:

$-241.60M

P/E Ratio:

-11.30

EPS:

-6.6167

Net Cash Flow:

$-201.34M

1W Performance:

+5.64%

1M Performance:

+9.78%

6M Performance:

-6.91%

1Y Performance:

+38.15%

1-Day Range:

$69.44

$75.00

1-Week Range:

$69.44

$75.00

52-Week Range:

$40.00

$99.50

Disc Medicine Inc Stock (IRON) Company Profile

Name

Disc Medicine Inc

Sector

Healthcare (1095)

Industry

Biotechnology (615)

Phone

(617) 674-9274

Address

321 ARSENAL STREET, SUITE 101, WATERTOWN

Employee

155

Twitter

Next Earnings Date

2026-08-06

Latest SEC Filings

IRON's Discussions on Twitter

Compare IRON vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
IRON Disc Medicine Inc	74.78	2.86B	0	-241.60M	-201.34M	-6.6167
VRTX Vertex Pharmaceuticals Inc	491.34	124.70B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	632.90	66.35B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	887.18	55.17B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	291.37	38.90B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	182.08	38.71B	742.00K	-1.37B	-1.07B	-7.0731

Disc Medicine Inc Stock (IRON) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-03-25	Resumed	Stifel	Buy
Jul-21-25	Initiated	Truist	Buy
Jul-03-25	Resumed	Morgan Stanley	Overweight
Jun-11-25	Resumed	Raymond James	Strong Buy
Feb-27-25	Initiated	TD Cowen	Buy
Nov-05-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Nov-04-24	Upgrade	Raymond James	Outperform → Strong Buy
Oct-23-24	Initiated	Jefferies	Buy
Oct-16-24	Initiated	Scotiabank	Sector Outperform
Aug-22-24	Initiated	Wells Fargo	Overweight
Apr-01-24	Downgrade	Raymond James	Strong Buy → Outperform
Dec-19-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jun-09-23	Upgrade	Raymond James	Outperform → Strong Buy
Jun-07-23	Initiated	H.C. Wainwright	Buy
May-17-23	Initiated	Raymond James	Outperform
Apr-28-23	Initiated	Cantor Fitzgerald	Overweight
Apr-21-23	Initiated	Stifel	Buy
Apr-20-23	Initiated	Morgan Stanley	Overweight
Mar-23-23	Initiated	BMO Capital Markets	Outperform
Feb-28-23	Initiated	SVB Securities	Outperform

View All

Disc Medicine Inc Stock (IRON) Latest News

Jun 28, 2026

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Embecta Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EMBC - GlobeNewswire Inc.

Jun 28, 2026

IRON (NASDAQ: IRON) notice: proposed 2,500-share option sale; prior 7,500-share 10b5-1 - Stock Titan

Jun 26, 2026

Disc Medicine, Inc. Actuals & Estimates (NASDAQ:IRON) - TradingView

Jun 26, 2026

Jun 25, 2026

Form 4 Disc Medicine Inc For: 24 June By Investing.com - Investing.com Australia

Jun 25, 2026

Jun 24, 2026